Back to Search Start Over

Feasibility of a longitudinal statistical atlas model to study aortic growth in congenital heart disease.

Authors :
Sophocleous F
Bône A
Shearn AIU
Forte MNV
Bruse JL
Caputo M
Biglino G
Source :
Computers in biology and medicine [Comput Biol Med] 2022 May; Vol. 144, pp. 105326. Date of Electronic Publication: 2022 Feb 28.
Publication Year :
2022

Abstract

Studying anatomical shape progression over time is of utmost importance to refine our understanding of clinically relevant processes. These include vascular remodeling, such as aortic dilation, which is particularly important in some congenital heart defects (CHD). A novel methodological framework for three-dimensional shape analysis has been applied for the first time in a CHD scenario, i.e., bicuspid aortic valve (BAV) disease, the most common CHD. Three-dimensional aortic shapes (n = 94) reconstructed from cardiovascular magnetic resonance imaging (MRI) data as surface meshes represented the input for a longitudinal atlas model, using multiple scans over time (n = 2-4 per patient). This model relies on diffeomorphism transformations in the absence of point-to-point correspondence, and on the right combination of initialization, estimation and registration parameters. We computed the shape trajectory of an average disease progression in our cohort, as well as time-dependent parameters, geometric variations and the average shape of the population. Results cover a spatiotemporal spectrum of visual and numerical information that can be further used to run clinical associations. This proof-of-concept study demonstrates the feasibility of applying advanced statistical shape models to track disease progression and stratify patients with CHD.<br /> (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1879-0534
Volume :
144
Database :
MEDLINE
Journal :
Computers in biology and medicine
Publication Type :
Academic Journal
Accession number :
35245697
Full Text :
https://doi.org/10.1016/j.compbiomed.2022.105326